Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor
- PMID: 3128601
Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor
Erratum in
- J Immunol 1988 Jul 15;141(2):709
Abstract
Bone marrow cells from C3H/HeJ mice were cultured in recombinant granulocyte-macrophage-CSF (rGM-CSF) or recombinant or purified (natural) preparations of macrophage-CSF (CSF-1) for 7 days, the adherent macrophages removed enzymatically, recultured in the absence of growth factor, and examined for their differentiative and functional characteristics. Expression of Ia Ag differed markedly in these two populations. Antibody plus complement-mediated cytotoxicity indicated that the percent of Ia-positive macrophages was low (approximately 15 to 20%) in both populations. Treatment of cultures with rIFN-gamma increased the percentage of Ia-positive cells in both populations; however, more CSF-1-derived macrophages were induced to become Ia positive than rGM-CSF-derived macrophages. In contrast, total Ia expression and Ia density per cell, as measured by ELISA and quantitative immunofluorescence, respectively, showed that medium-treated rGM-CSF-derived macrophages exhibited greater total Ia expression and higher Ia density per cell than CSF-1-derived macrophages. Treatment of CSF-1-derived macrophages with rIFN-gamma increased total Ia expression per culture to the levels exhibited by rGM-CSF-derived cells, although the density of Ia Ag per cell remained lower than in rGM-CSF-derived cells (medium or rIFN-gamma-treated). Northern blot and slot blot analysis of cytoplasmic RNA extracted from freshly harvested rGM-CSF- or CSF-1-derived cells indicated that the differences seen in basal Ia expression were also reflected at the level of steady-state, Ia-specific mRNA. The functional capacity of these two macrophage populations to stimulate Ag-specific T cell proliferation was also assessed. rGM-CSF- or CSF-1-derived macrophages were first cultured in the absence or presence of rIFN-gamma, Ag-pulsed, and irradiated before co-culture with Ag-primed, purified T cells. Ag-induced T cell proliferation was significantly greater in rGM-CSF- than in CSF-1-derived macrophages. Treatment of either population with rIFN-gamma had only a minimal effect on the ability of either macrophage population to stimulate Ag-specific T cell proliferation. These findings suggest that the development of mature macrophages from bone marrow progenitors under the influence of either GM-CSF or CSF-1 may, in part, underlie the functional heterogeneity of different macrophage populations.
Similar articles
-
Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function.J Immunol. 1988 Dec 1;141(11):3882-8. J Immunol. 1988. PMID: 3141506
-
Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.Eur J Immunol. 1988 Aug;18(8):1151-8. doi: 10.1002/eji.1830180802. Eur J Immunol. 1988. PMID: 3138135
-
Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons.J Immunol. 1985 Feb;134(2):982-9. J Immunol. 1985. PMID: 2578168
-
Selection of the delayed hypersensitivity T effector and T suppressor cell response by antigen-presenting macrophages.Immunobiology. 1984 Dec;168(3-5):246-59. doi: 10.1016/S0171-2985(84)80114-X. Immunobiology. 1984. PMID: 6241600 Review.
-
Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF). A review of its pharmacological properties and prospective role in the management of myelosuppression.Drugs. 1992 Apr;43(4):516-60. doi: 10.2165/00003495-199243040-00008. Drugs. 1992. PMID: 1377118 Review.
Cited by
-
Modulation of accessory cell function of immortalized bone marrow-derived macrophages by granulocyte/macrophage colony-stimulating factor.Med Microbiol Immunol. 1993 Jul;182(3):153-66. doi: 10.1007/BF00190268. Med Microbiol Immunol. 1993. PMID: 7901744
-
Granulocyte-macrophage colony-stimulating factor augments lymphokine-activated killer activity from pleural cavity mononuclear cells of lung cancer patients without malignant effusion.Jpn J Cancer Res. 1995 Sep;86(9):861-6. doi: 10.1111/j.1349-7006.1995.tb03097.x. Jpn J Cancer Res. 1995. PMID: 7591964 Free PMC article.
-
Production of reactive nitrogen intermediates by bone marrow-derived macrophages on treatment with cisplatin in vitro.Clin Exp Immunol. 1992 Sep;89(3):502-8. doi: 10.1111/j.1365-2249.1992.tb06989.x. Clin Exp Immunol. 1992. PMID: 1516267 Free PMC article.
-
Production of cytokines and PGE2 and cytotoxicity of stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages.Inflammation. 1993 Oct;17(5):583-94. doi: 10.1007/BF00914196. Inflammation. 1993. PMID: 8225565
-
Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937.Immunology. 1993 Jun;79(2):229-35. Immunology. 1993. PMID: 8344702 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous